Pediatric Pharmacoepidemiology

(204) A Real-World Study of Incidence Rates of Safety Outcomes of Interest in Infants Aged 1 Month to < 1 Year and Patients Aged 1 to < 2 Years Treated with Intravenous Pantoprazole Sodium Using an Electronic Health Records Database from the US

(181) Acid Suppressive Medication and The Incidence of Chronic Childhood Immunological Diseases: A Scoping Review

(200) Characterizing Infants in The Sentinel Distributed Database Mother-Infant Linkage Table

(201) Characterizing Pediatric Members in The Sentinel Distributed Database

(186) Common Diagnoses, Procedures and Medications in The First Year of An Infant's Life

(187) Continued Benefits of Pharmacological Treatment of ADHD on Unintentional Injuries: Emulation of a Target Trial with Swedish Real-World Data

(195) Differences in Psychotropic Drug Use Among Children and Adolescents in Scandinavia

(X) Association Between Antihistamine Exposure and Newly Diagnosed Juvenile Idiopathic Arthritis: A Nationwide Analysis

(T) Association Between Prenatal Antipsychotic Exposure and The Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

(U) Outpatient Antibiotic Prescribing in Early Life: A Population-Based Study Comparing Birth Cohorts from Denmark and Germany

(R) Risk of Infection in Children with Psoriasis Receiving Treatment with Ustekinumab, Etanercept, or Methotrexate

(V) Trends in Psychotropic Prescriptions Dispensed to US Children Early in the COVID-19 Pandemic

(Q) Trends in The Incidence of Varicella Cases with Complications Among Korean Children During 2010-2020 After the Universal One-Dose Varicella Vaccination Program

(Y) Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from The Sentinel Distributed Database, 2008-2020

(189) Epidemiology of Pediatric Ewing Sarcoma in the United States

(188) Healthcare Utilization and Treatment Among Newly Diagnosed and Prevalent Children with Juvenile Idiopathic Arthritis During the First Year of COVID-19 Pandemic in the US

(197) Maternal Antibiotics Use in Pregnancy and The Risk of Neurodevelopmental Disorders in Children: A Systematic Review and Meta-Analysis

(203) New Child and Adolescent Users of Psychotropic Medication After the Start of the COVID-19 Pandemic

(202) Pediatric Drug Safety Surveillance in Saudi Arabia: A Description of Adverse Drug Reactions from The Saudi Vigilance Database

(199) Potential Drug-Drug Interactions in Pediatric Patients with Cancer: A Hospital-Based Prospective Study

(194) Prescription Pattern of Empirical Antibiotic Used and The Factors Affecting Death in Children with Bacteremia in Taiwan

(183) Prevalence and Factors Associated with Guideline Concordant Antiviral Treatment in Children at High Risk for Influenza Complications

(185) Prevalence of Childhood and Adolescent Overweight/Obesity in South Asian Countries: A Systematic Review and Meta-Analysis

(198) Reports of Adverse Events Related with Second Generation Antipsychotics in Children in The FDA Adverse Event Reporting System (FAERS)

(192) Safety and Effectiveness of Inhaling Different Dosage Recombinant Human Interferon Α1b for Bronchiolitis in Children: A Systematic Review and Meta-Analysis

(196) So Many Countries, So Many Customs: A Register-Based Analysis of Conduct Disorder Prevalence and Treatment Patterns in Four Western Countries

(193) Stimulant Drug Use in Children Before Six Years of Age and Antipsychotic Add-on Therapy: A Population Based Longitudinal Study

(184) The Challenges with Identifying Pediatric Recurrent Wheezing in Real World Data

(182) Tolerated Juvenile Idiopathic Arthritis Disease Activity States in The Childhood Arthritis and Rheumatology Research Alliance Registry

(190) Trends in Antiviral Use for Influenza Among Children in the US Between 2010-2019